CRISPR Therapeutics AG
COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A
Last updated:
Abstract:
Provided include materials and methods for treating Hemophilia A in a subject ex vivo or in vivo. Also provided include materials and methods for knocking in a FVIII-encoding gene in a genome, in particular the locus of albumin gene.
Status:
Application
Type:
Utility
Filling date:
17 Oct 2018
Issue date:
17 Mar 2022